Press Releases
Eisai presents Non-Clinical Research Findings in 107th Annual Meeting of American Association for Cancer Research
Enhanced Mechanism Of Angiogenesis Inhibition And Anti-Tumor Activity In Renal Cell Carcinoma Investigated World pharma today/Press releases /-Eisai Co Ltd. announced that...
Press Releases
Merck Receives Breakthrough Therapy Designation from U.S. FDA for KEYTRUDA® in Classical Hodgkin Lymphoma (cHL)
Merck known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...
Press Releases
Bayer to present latest preclinical data on oncology compounds in 107th Annual Meeting of American Association for Cancer Research
Bayer will present latest preclinical data on oncology compounds, which are currently in preclinical or early clinical development stage at the American Association for Cancer...
Press Releases
Kanuma receives marketing approval in Japan for Treatment of Patients with Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc announced that Japan’s Ministry of Health, Labour and Welfare has approved Kanuma for the treatment of patients of all ages in Japan...
Press Releases
Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients With Rheumatoid Arthritis Who Had Inadequate Response To Biologics
Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced that detailed results of RA-BEACON — a pivotal phase 3 global study of...
Press Releases
Proteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for People with Cystic Fibrosis
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing. such...
Press Releases
ASLAN Pharmaceuticals named Asian Biotech of the year
ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types, has been named ‘Asian Biotech...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.